![](https://bioengineer.org/wp-content/uploads/2024/06/Pre-targeted-dual-isotope-radionuclide-therapy-safe-and-effective-in-colorectal-cancer.jpeg)
Pre-targeted dual-isotope radionuclide therapy safe and effective in colorectal cancer
Toronto, Ontario—Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual meeting. This …